Real-world analysis of the celgene global drug safety database: Early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Lilia Weiss, Dianna Gary, Arlene S. Swern, John Freeman, Mary M. Sugrue

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Real-world analysis of the celgene global drug safety database: Early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science